Top Markets
#1 Akedo Akedo +54.06%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.26%
#4 Cross Cross +47.18%
#5 Black Phoenix Black Phoenix +34.15%
#6 Velvet Velvet +31.77%
#7 OVERTAKE OVERTAKE +18.70%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.05%
#9 Movement Movement +13.43%
#10 Perle Perle +11.98%
Coin of the day
Akedo Akedo
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang in aandelen #38984
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Aandeelprijs
$0.0601
Marktkapitalisatie
$699.79K
Verandering (1 dag)
-14.14%
Verandering (1 jaar)
0.17%
Land
US
Handel Hepion Pharmaceuticals, Inc. (HEPA)

Categorie

Healthcare
Prijs HEPA met de marktkapitalisatie van B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0601
Marktkapitalisatie van Hepion Pharmaceuticals, Inc.(HEPA)
Marktkapitalisatie: $699.79K
Vanaf August 2026 heeft Hepion Pharmaceuticals, Inc. een marktkapitalisatie van $699.79K. Dit maakt Hepion Pharmaceuticals, Inc. volgens onze gegevens het 38984th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Hepion Pharmaceuticals, Inc. van 2014 tot 2026
HEPA vergeleken met de top 5 populairste stocks
Prijs voor HEPA Aandeel B Marktkapitalisatie van B uitslagen
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$468,344 $699.79K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.453T +779,274,378.09%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$385,276 $699.79K
Apple Inc. Apple Inc.
AAPL
$4.486T +641,058,886.97%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$357,546 $699.79K
Alphabet Inc. Alphabet Inc.
GOOG
$4.163T +594,918,186.45%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,016 $699.79K
Microsoft Corporation Microsoft Corporation
MSFT
$3.691T +527,480,555.97%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$244,167 $699.79K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.843T +406,267,222.72%